跳到主要内容

UPEXI, INC. (UPXI) Stock Forecast 2025 - AI Price Prediction & Analysis


UPEXI, INC. (UPXI) AI Stock Price Forecast & Investment Analysis

UPEXI, INC. Stock Price Chart and Technical Analysis

Loading UPEXI, INC. interactive price chart and technical analysis...

UPEXI, INC. (UPXI) - Comprehensive Stock Analysis & Investment Research

Deep dive into UPEXI, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about UPEXI, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For UPEXI, INC.: UPEXI, INC. operates in the Life Sciences sector, making it an emerging small-cap investment.

UPEXI, INC. (Stock Symbol: UPXI) is a leading company in the Life Sciences sector , specifically operating within the Medicinal Chemicals & Botanical Products industry.

The organization employs approximately 5 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing UPEXI, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For UPEXI, INC.: With $-26M in annual revenue and 86.2% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $-26 million generating a 86.2% net profit margin .

Market Capitalization: $279 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for UPEXI, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For UPEXI, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for UPEXI, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: UPEXI, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For UPEXI, INC.: Market positioning analysis based on available financial and operational metrics.

UPEXI, INC. strategically competes in the highly dynamic Medicinal Chemicals & Botanical Products marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy -1.6% gross margin, indicating strong pricing power and operational efficiency.

UPEXI, INC. (UPXI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for UPEXI, INC. stock analysis.

Loading UPEXI, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into UPEXI, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if UPEXI, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For UPEXI, INC.: With a P/E ratio of -10.63, the market sees the stock as potentially undervalued.

P/E Ratio -10.63x
P/B Ratio 150.67x
Market Cap $279M
EPS $-0.23
Book Value/Share $1.29
Revenue/Share $2.96
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently UPEXI, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For UPEXI, INC.:

Gross Margin -1.6%
Operating Margin 78.9%
Net Margin 86.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess UPEXI, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For UPEXI, INC.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal UPEXI, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For UPEXI, INC.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively UPEXI, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For UPEXI, INC.:

Understanding Financial Statement Data

What these metrics mean: Key figures from UPEXI, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For UPEXI, INC.: With annual revenue of $-26M, UPEXI, INC. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $-26M
Operating Income $-20M
Net Income $-22M
Cost of Goods Sold $38M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 1M
Growth Metrics (YoY)
EPS Growth -4.6%

Latest UPEXI, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting UPEXI, INC. (UPXI) stock price and investment outlook.

, source: The Globe and Mail

Upexi is a brand owner specializing in the development, manufacturing, and distribution of consumer products. The Company has entered the cryptocurrency industry and cash management of assets through ...

, source: Morningstar

TAMPA, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification ...

UPEXI, INC. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of UPEXI, INC. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAWH Unlock Forecast - 30 Days FREE Trial $153M x 5.6x
AIBT Unlock Forecast - 30 Days FREE Trial $0M x x
AYRWF Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BTMD Unlock Forecast - 30 Days FREE Trial $388M 15.7x -3.0x
CBDY Unlock Forecast - 30 Days FREE Trial $1M x x
CDXC Unlock Forecast - 30 Days FREE Trial $536M -666.2x 11.6x
CGC Unlock Forecast - 30 Days FREE Trial $202M -0.3x 0.4x
CRON Unlock Forecast - 30 Days FREE Trial $1023M 55.3x 0.9x
CURLF Unlock Forecast - 30 Days FREE Trial $2769M x 3.2x
CXXIF Unlock Forecast - 30 Days FREE Trial $41M x 1.4x
CYAN Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.3x
FTLF Unlock Forecast - 30 Days FREE Trial $120M 19.3x 3.1x
GHBWF Unlock Forecast - 30 Days FREE Trial $37M x 0.3x
GLASF Unlock Forecast - 30 Days FREE Trial $811M x 7.0x
GLUC Unlock Forecast - 30 Days FREE Trial $0M x x
JUSHF Unlock Forecast - 30 Days FREE Trial $141M x x
MNMD Unlock Forecast - 30 Days FREE Trial $803M -3.1x 4.3x
MTEX Unlock Forecast - 30 Days FREE Trial $18M -55.4x 2.4x
NAGE Unlock Forecast - 30 Days FREE Trial $799M 45.1x 12.4x
NAII Unlock Forecast - 30 Days FREE Trial $26M -3.3x 0.3x
RAJAF Unlock Forecast - 30 Days FREE Trial $1020M x x
RAPH Unlock Forecast - 30 Days FREE Trial $4M x x
SMFL Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
SNYR Unlock Forecast - 30 Days FREE Trial $33M -551.3x -2.1x
TCNNF Unlock Forecast - 30 Days FREE Trial $1550M x 1.3x
TCRG Unlock Forecast - 30 Days FREE Trial $16M x x
TLRY Unlock Forecast - 30 Days FREE Trial $684M -4.1x 0.3x
UPXI Unlock Forecast - 30 Days FREE Trial $279M -10.6x 150.7x
USNA Unlock Forecast - 30 Days FREE Trial $570M 13.6x 1.1x

Frequently Asked Questions - UPEXI, INC. Stock Forecast

How accurate are UPEXI, INC. stock predictions?

Our AI model demonstrates -6% historical accuracy for UPXI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence UPEXI, INC. stock price forecasts?

Our analysis considers UPEXI, INC.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is UPEXI, INC. a good investment in 2025?

Based on our AI analysis, UPEXI, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are UPEXI, INC. forecasts updated?

UPEXI, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced UPEXI, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for UPEXI, INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...